News

As one of Chinese excellent pharmaceutical company representatives, Yan Li met with FDA director in Beijing University

ABOUT US

News

As one of Chinese excellent pharmaceutical company representatives, Yan Li met with FDA director in Beijing University

Release time：

2014-12-04

On November 17, 2014, Yan Li who is the general manager of Qilu attended the conference with FDA manager Dr. Margaret A.Hamburg in Beijing University.

During the conference, Yan Li introduced the quality culture of Qilu to Dr. Hamburg and the other officers of FDA. What’s more, she discussed with Dc. Hamburg about how to enter US market for Chinese pharmaceutical companies

Besides, Dr. Hamburg also made a speech with the topic of “Cope with the challenge of globalization, Strengthen international cooperation, Promote the healthy and safety”. Mr. Mary Lou Valdez who is the deputy director of FDA, Dr. Christopher Hickey who is the office director of FDA to China and another seven outstanding entrepreneurs representatives attended the conference simultaneously.

Qilu Pharmaceutical was listed in 2014 TOP100 companies in the chemical pharmaceutical industry of China

Ondansetron Hcl for Injection of Qilu was approved by USFDA

Related News

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list

2022-07-18

The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

2022-06-15

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company